Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss may indicate higher heart risk and metabolic issues.

Men with severe early-onset baldness may have worse heart artery function and stiffer arteries if they have high blood pressure.

Men with male pattern baldness have increased arterial stiffness.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

There's no significant link between hair loss from male pattern baldness and early heart disease.

Women with hair loss have higher heart disease risk and unhealthy cholesterol levels.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

More severe hair loss links to thicker heart fat, suggesting possible heart disease risk.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Balding men have higher heart disease risk.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Men with male pattern baldness are more likely to have heart disease risk factors, so they should get heart screenings early.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Obese women with PCOS are more likely to have fatty liver disease.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Women with premature ovarian insufficiency have a worse cardiovascular risk profile than premenopausal women.

Effective treatment for midlife women's hair loss is limited, with 5% minoxidil foam being the only proven option for the most common type.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.